Private Healthcare Delivery Sector in India 2020

Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

The private healthcare delivery sector includes any healthcare services provided by an individual or group that is profitable and is not controlled or operated by the government. It plays a fundamental role in the Indian healthcare sector by serving around 79% of the urban and 72% of the rural population. In terms of revenue, the private healthcare delivery sector in India was valued at INR 11,197.43 Bn in 2019, and is estimated to reach INR 34,135.53 Bn by 2025, expanding at a CAGR of ~16.60% during the 2020 - 2025 period.
Segment insights:
The private healthcare delivery sector has three major segments - the private hospital sector, the private diagnostics sector, and the pharmacy retail sector. The private hospital sector was the largest segment, holding a market share of ~78.11% in 2019. The market share of the private diagnostics segment is estimated to increase sizeably to reach ~12.62% by 2025.
The private hospital sector has witnessed significant growth over the past few years, backed by private equity investments. The major private hospitals in India are concentrated in urban and semi-urban areas. The players in the sector are focusing on expanding their network of super-specialty and multi-specialty hospitals in tier II and tier III cities in India.
The private diagnostics sector is anticipated to exhibit a massive growth over the forecast period, on account of an increase in preventive healthcare and evidence-based treatment in India. The sector is largely fragmented and consists of hospital-based labs, standalone centers, and large diagnostic chains.
Pharmacy retail was the second-leading segment of the private healthcare delivery sector in Indian in 2019. An increase in the patient pool of those suffering from chronic illnesses, coupled with better affordability, has driven the pharmacy retail segment. With the improved digital infrastructure of the country, the online pharmacy sub-segment is expected to create immense opportunities in the market.
Impact of COVID-19:
The pandemic has had a huge impact on the private healthcare delivery sector in terms of business operations and financial performance. The enforcement of the stringent lockdown led to a steep decline in the number of patients in private hospitals, as well as diagnostic centers. The cancellation of elective surgeries and the closure of outdoor patient departments have caused a sharp decrease in industry revenue. Furthermore, travel restrictions and the closure of inter-state borders created blockages in the supply chain and logistics. However, strategies, including digital transformation, capacity expansion, and increased collaborations with vendors have improved sustainability and aided the recovery of the sector.
Companies covered:
• Apollo Hospitals Enterprise Ltd
• Dr. Lal PathLabs Ltd.
• Fortis Healthcare Ltd.
• HealthCare Global Enterprises Ltd.
• Max Healthcare Institute Ltd.
• Narayana Hrudayalaya Ltd.
• Shalby Ltd.
• Netmeds Marketplace Ltd.
• 1mg
• 91Streets Media Technologies Private Limited (PharmEasy)

Chapter 1: Executive summary

Chapter 2: Socio-economic indicators

Chapter 3: Introduction
3.1. Market definition and structure

Chapter 4: Market overview
4.1. India private healthcare delivery sector overview
4.1.1. Market size and growth forecast (2019 - 2025e)

Chapter 5: Market segmentation
5.1. Private healthcare delivery sector in India - segmentation by type
5.1.1. India private healthcare delivery sector share (%) (2019 & 2025e)
5.1.2. India private hospital market size and growth forecast (2019 - 2025e) Private hospital sector in India - Segmentation by payer mix
5.1.3. India private diagnostics market size and growth forecast for government payer (2019 - 2025e) Private diagnostic sector in India - Segmentation by test type Private diagnostic sector in India - Segmentation by lab type Private diagnostic sector in India - Segmentation by client type Private diagnostic sector in India - Segmentation by location
5.1.4. India pharmacy retail market size and growth forecast (2019 - 2025e) Pharmacy retail sector in India - Segmentation by retail channel Pharmacy retail sector in India - Segmentation by drug type

Chapter 6: Impact of COVID-19
6.1. Impact on private hospital sector
6.2. Impact on private diagnostics sector
6.3. Impact on pharmacy retail sector

Chapter 7: Market influencers
7.1. Market drivers
7.2. Market challenges
Chapter 8: Market consolidation
8.1. Consolidation in private hospital sector
8.2. Consolidation in private diagnostics sector
8.3. Consolidation in pharmacy retail sector

Chapter 9.1 Competitive landscape
9.1. Apollo Hospitals Enterprise Ltd.
9.1.1. Company information
9.1.2. Business description
9.1.3. Products/Services
9.1.4. Key people
9.1.5. Financial snapshot
9.1.6. Key ratios
9.1.7. Key financial performance indicators
9.1.8. Key business segments
91.9. Key geographical segments
Note: Similar information covered for all other public companies
9.2. Dr. Lal PathLabs Ltd.
9.3. Fortis Healthcare Ltd.
9.4. HealthCare Global Enterprises Ltd.
9.5. Max Healthcare Institute Ltd.
9.6. Narayana Hrudayalaya Ltd.
9.7. Shalby Ltd.
9.8. Netmeds Marketplace Ltd.
9.9. 1mg
9.10. 91Streets Media Technologies Private Limited (PharmEasy)

Chapter 10: Recent developments
10.1. Recent developments
Chapter 11: Appendix
11.1. Research methodology
11.2. About Netscribes
11.3. Disclaimer

Choose License Type

Happy To Assist You

Contact Images

We will be happy to help you find what you need. Please call us or write to us:

Frequently Asked Questions

This report incorporates the analysis of factors that augments the market growth. Report presents competitive landscape of the global market. This also provides the scope of different segments and applications that can potentially influence the market in the future. The analysis is based on current market trends and historic growth data. It includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xxx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by:
  • Product Types
  • Drug Class
  • Indication
  • Applications
  • Services Types
  • End-users
  • Distribution channel
  • Regions
The report share key insights on the following:
  • Current market size
  • Market forecast
  • Market opportunities
  • Key drivers
  • Restraints
  • Pipeline Analysis
  • Incidence Rate
  • Epidemiology Analysis
  • Prevalence rate
  • Regulatory scenario
  • Industry trend
  • Pestle Analysis
  • Porter’s Analysis
  • New product approvals/launch
  • Promotion and marketing initiatives
  • Pricing analysis
  • Export-import analysis
  • Trade analysis
  • Competitive landscape
It helps the businesses in making investments decisions.
Customization helps the organization to gain insight on specific segments and regions of interest. Thus, WMR offers tailored report information based on business requirement in order to take strategic calls.
Contact us

Sales Office (U.S.):
Worldwide Market Reports, 1001 4th Ave, #3200 Seattle, WA 98154, U.S.


Asia Pacific Intelligence Center (India):
Worldwide Market Reports, 403, 4th Floor, Bremen Business Center, Aundh, Pune, Maharashtra 411007, India.


Want us to send you latest updates of the current trends, insights, and more, signup to our newsletter (for alerts, special offers, and discounts).

Secure Payment By:

This website is secured Origin CA certificate on the server, Comodo, Firewall and Verified Sitelock Malware Protection


© 2021 Worldwide Market Reports. All rights reserved